Uncategorized
Glaukos Announces Participation in September Investor Conferences
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference on Thursday, September 10, 2020 at 11:00 a.m. PDT J.P. Morgan 11th Annual U.S. All Stars Conference on Tuesday,